Besides, it has been further unveiled that LINC00886 impacts the malignant progression and immune evasion of ovarian cancer by modulating miR-423-5p and the downstream TLR4 signaling pathway, offering a fresh perspective for therapeutic interventions in ovarian cancer. This evidence concerns the gene TIPARP-AS1 and ovarian carcinoma.